
Acquired Resistance to Therapy Network (ARTNet)
@NCIARTNet
Followers
387
Following
494
Media
166
Statuses
568
Official Account of @theNCI Acquired Resistance to Therapy Network (ARTNet). https://t.co/4EHNl98ody
Joined April 2020
The Acquired Resistance to Therapy Network (ARTNet), of @theNCI focuses on mechanisms of acquired resistance to cancer therapies & disease recurrence and integrates those findings through team science. Learn more at and
cancer.gov
Acquired Resistance to Therapy Network (ARTNet) focuses on the mechanistic bases of acquired resistance to cancer therapies and disease recurrence. Its goal is to balance basic, pre-clinical, and...
0
1
3
Check out the latest research by ARTNet PI Dr @BoyiGan and his team at @MDAndersonNews linking hypoxia-mediated chromatin regulation to phospholipid metabolism and ferroptosis resistance in cancer. Out now @MolecularCell 👇.
0
0
2
RT @CD_AACR: In the Spotlight: Toward Response-Adaptive Therapy in Locally Advanced NSCLC: Integrating ctDNA and Radiomics for Risk Stratif….
0
5
0
RT @Cancer_Cell: Online Now: A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers h….
0
51
0
RT @NatureRevCancer: #ResearchHighlight . In a study published in #Cell, Phelps et al. find a mechanism connecting exercise, gut microbiota….
nature.com
Nature Reviews Cancer - In a study published in Cell, Phelps et al. find a mechanism connecting exercise, gut microbiota and anti-tumour immunity; exercise induces microbiota to produce formate,...
0
9
0
RT @NatureCancer: 🚨ARTICLE now published @NatureCancer !. ✏️By Valsamo Anagnostou and colleagues. 'Combination of pembrolizumab and radioth….
nature.com
Nature Cancer - Huang et al. analyzed serial samples from participants with metastatic non-small cell lung cancer treated with radiotherapy followed by immunotherapy and report improved clinical...
0
28
0
RT @VRodriguezBravo: Very excited about our last paper in @CD_AACR on the role of off-pore nucleoporins in #prostatecancer progression & im….
0
5
0
RT @NCICAPIT: Don't wait-register now for the CAP-IT Virtual Annual Summit on July 24, 2025! .Open to the public with exciting talks on can….
0
4
0
Reactome is an open-source, peer-reviewed pathway database providing intuitive tools for visualizing and analyzing molecular pathways, advancing research, genomics, and systems biology since 2003. Co-led by Dr. Guanming Wu of the ARTNet U54 center at @OHSUNews. Explore:.
0
1
3
RT @NCICAPIT: This new paper from CAP-IT U24 center @RoswellPark proposes a machine learning-assisted inferential procedure under Rosenbaum….
0
3
0
RT @SeanPitroda: 📢 New in Cancer Cell: Radiotherapy is essential for local control—but can it unintentionally accelerate growth of distant….
0
46
0
RT @EGFRResisters: Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutatio….
nature.com
Scientific Reports - Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutations: a prospective cohort study
0
15
0
RT @ImmunityCP: Online now: Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint i….
cell.com
Pancreatic ductal adenocarcinoma is an aggressive cancer characterized by an immunosuppressive tumor microenvironment and limited therapeutic options. Mahat et al. show that a prevalent p53 mutation...
0
12
0
RT @Nature: Nature research paper: Nerve-to-cancer transfer of mitochondria during cancer metastasis.
0
167
0
RT @NIH: Are you an early stage researcher? Check out the newly released #FundingOpportunity for the #NIH Director’s New Innovator Award to….
0
45
0
RT @Cancer_Cell: Online Now: Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangi….
0
60
0
If you use Spearman (or Pearson) correlation p-values from standard software… there's a 99.9% chance they’re wrong. Drs. Han Yu and Alan Hutson @Amherst73 of @RoswellPark reveal why in "A robust Spearman correlation coefficient permutation test" , the top-cited article of the.
0
0
0